HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 129 filers reported holding HARROW HEALTH INC in Q3 2023. The put-call ratio across all filers is 5.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,409 | -59.2% | 5,874 | -45.9% | 0.00% | – |
| Q2 2023 | $206,908 | -84.2% | 10,867 | -82.4% | 0.00% | – |
| Q1 2023 | $1,306,122 | +13087.8% | 61,726 | +9099.1% | 0.00% | – |
| Q4 2022 | $9,904 | +395.2% | 671 | +301.8% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 167 | +2.5% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 163 | +10.1% | 0.00% | – |
| Q3 2021 | $1,000 | -98.3% | 148 | -97.7% | 0.00% | – |
| Q2 2021 | $60,000 | -96.9% | 6,501 | -97.7% | 0.00% | – |
| Q1 2021 | $1,924,000 | +205.4% | 285,066 | +210.9% | 0.00% | – |
| Q4 2020 | $630,000 | +84.2% | 91,683 | +50.0% | 0.00% | – |
| Q3 2020 | $342,000 | +41.9% | 61,120 | +32.5% | 0.00% | – |
| Q2 2020 | $241,000 | +89.8% | 46,128 | +38.4% | 0.00% | – |
| Q1 2020 | $127,000 | -41.5% | 33,323 | +19.7% | 0.00% | – |
| Q4 2019 | $217,000 | +21.9% | 27,833 | -11.6% | 0.00% | – |
| Q3 2019 | $178,000 | +12.7% | 31,473 | +74.4% | 0.00% | – |
| Q2 2019 | $158,000 | – | 18,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |